Androgen Excess: A Hallmark of Polycystic Ovary Syndrome

December 2023 in “ Frontiers in endocrinology ”

Kexin Wang, Yanhua Li, Yu Chen

androgen excess polycystic ovary syndrome PCOS hyperandrogenism androgen synthesis androgen conversion androgen metabolism adrenal-derived 11-oxygenated androgen androgen receptor signaling high androgen levels androgen production androgen processing androgen breakdown adrenal androgens androgen signaling

Studysummary This review explores the role of hyperandrogenism, including adrenal-derived 11-oxygenated androgen, in the development of polycystic ovarian syndrome and discusses potential therapeutic strategies targeting androgen excess, without reporting new clinical results.

Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer

View this study on frontiersin.org →

Discuss this study in the Community →

Research cited in this study

10 / 10 results

research Do Pleiotropic Effects of Spironolactone in Women With PCOS Make It More Than an Anti-Androgen? Evidence From a Systematic Review and Meta-Analysis

March 2023 in “Current Pharmaceutical Design”

This study found that spironolactone significantly reduced hirsutism scores in women with idiopathic hirsutism compared to finasteride and cyproterone acetate but showed no significant difference among women with PCOS compared to flutamide and finasteride, and it was well tolerated overall.

research Oral Contraceptive Pill Treatment Alters Gene Expression of Inflammatory Markers in Polycystic Ovary Syndrome Women

2 citations , February 2023 in “BMC women's health”

In this study, oral contraceptive use in women with PCOS increased the expression of certain inflammatory gene markers, which were positively associated with metabolic abnormalities.

research Approach to Investigation of Hyperandrogenism in a Postmenopausal Woman

November 2022 in “The Journal of Clinical Endocrinology and Metabolism”

This review discusses the causes and recommended clinical investigations for postmenopausal hyperandrogenism, highlighting the role of androgen excess in symptoms like hirsutism and its association with metabolic disorders.

research Reconsidering the Polycystic Ovary Syndrome (PCOS)

41 citations , June 2022 in “Biomedicines”

This study proposes reclassifying PCOS into two distinct phenotypes based on androgen levels and suggests androgen supplementation may overcome IVF resistance in one group with advancing age.

research Basics of Androgen Synthesis and Action

35 citations , May 2022 in “Baillière's best practice and research in clinical endocrinology and metabolism/Baillière's best practice & research. Clinical endocrinology & metabolism”

This review discusses the current understanding of androgen biosynthesis, mechanisms of action, and their roles in human biology, as well as related congenital and acquired disorders, but it reports no new research findings.

research 11-Oxyandrogens in Adolescents With Polycystic Ovary Syndrome

9 citations , March 2022 in “Journal of the Endocrine Society”

This study found that testosterone more accurately predicts PCOS diagnosis than 11-oxyandrogens, which were linked with hirsutism severity and showed varying responses to contraceptive and metformin treatments.

research Androgens and Ovarian Function: Translation from Basic Discovery Research to Clinical Impact

55 citations , May 2019 in “Journal of Endocrinology”

This review summarizes research on androgens' roles in female reproductive function, noting their impact on IVF outcomes and the development of PCOS, and highlights the need for mechanism-based therapies.

research Effects of Melatonin Supplementation on Hormonal, Inflammatory, Genetic, and Oxidative Stress Parameters in Women With Polycystic Ovary Syndrome

81 citations , May 2019 in “Frontiers in Endocrinology”

This study found that administering melatonin for 12 weeks to women with PCOS significantly reduced hirsutism, testosterone, and inflammation markers, while enhancing antioxidant levels compared to a placebo.

research 5α-Reductase Activity in Women with Polycystic Ovary Syndrome: A Systematic Review and Meta-Analysis

20 citations , March 2017 in “Reproductive Biology and Endocrinology”

Women with PCOS have higher 5α-reductase activity, which may be linked to insulin resistance.

research Polymorphism of CAG and GGN Repeats of Androgen Receptor Gene in Women with Polycystic Ovary Syndrome

9 citations , September 2015 in “Reproductive Biomedicine Online”

This study suggests that longer GGN repeat polymorphisms in the androgen receptor gene are associated with polycystic ovary syndrome in women.